OPEN END INDEX-CERTIFICATE - AMGEN | Market Closed - Euronext Paris 10:00:01 15/07/2024 pm IST | ||
| 1.295 EUR | -0.15% |
|
| Current month | +3.93% | ||
| 1 month | +8.64% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 15/24/15 | 1.295 | -0.15% |
| 12/24/12 | 1.297 | +1.09% |
| 11/24/11 | 1.283 | +1.10% |
| 10/24/10 | 1.269 | +2.84% |
| 09/24/09 | 1.234 | +0.41% |
Real-time Euronext Paris
Last update July 15, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Certificados de Índices y Participaciones |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| J833S | |
| ISIN | FRSGE001LLF4 |
| Date issued | 27/04/2023 |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 0.91 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.311 € |
|---|---|
| Lowest since issue | 0.836 € |
| Spread | 0.006 € |
| Spread % | 0.46% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Certificates
- J833S Certificat
